CarolAShermanMD

Oncology • Mount Pleasant, SC

Associate Professor of Medicine, Med University SC

Join to view full profile

Dr. Sherman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sherman's full profile

Already have an account?

Office
1600 Midtown Ave
Mount Pleasant, SC 29464
Phone+1 843-792-9300
Is this information wrong?

Education & Training

UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1987 - 1989
UMass Chan Medical SchoolResidency, Internal Medicine, 1984 - 1987
University of Massachusetts Medical SchoolClass of 1984

Certifications & Licensure

SC State Medical License 1997 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer Start of enrollment: 1998 Nov 01
Completed
Phase 2
Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers Start of enrollment: 2009 Nov 01
Completed
Phase 1
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

265 citations
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John Wrangle, Vamsidhar Velcheti, Manish R. Patel, Elizabeth Garrett-Mayer, Elizabeth G. Hill, James G. Ravenel, Jeffrey S. Miller, Mohammad Farhad, Kate Anderton, Kat...> ;The Lancet. Oncology. 2018 May 1
3 citations
Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.
Anastasios Dimou, Carol A. Sherman, John Wrangle> ;Journal of Thoracic Imaging. 2016 Jul 1
119 citations
Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib
Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer A. Logan, Elizabeth Kennedy, Priscilla K. Brastianos, Andrew S. Chi, Alice T. Shaw> ;Journal of Thoracic Oncology. 2015 Feb 1
9 citations
Biomarkers in the selection of maintenance therapy in non-small cell lung cancer.
Nichole T. Tanner, Carol A. Sherman, Gerard A. Silvestri> ;Translational Lung Cancer Research. 2012 Jun 30
22 citations
The role of molecular analyses in the era of personalized therapy for advanced NSCLC
Nichole T. Tanner, Nicholas J. Pastis, Carol A. Sherman, George R. Simon, David N. Lewin, Gerard A. Silvestri> ;Lung Cancer. 2012 May 1
4 citations
Toxicity, Response Rates and Survival Outcomes of Induction Cisplatin and Irinotecan Followed by Concurrent Cisplatin, Irinotecan and Radiotherapy for Locally Advanced...
John M. Watkins, A.J. Zauls, Patricia L. Kearney, Keisuke Shirai, Bree N. Ruppert, Jennifer L. Harper, Carol A. Sherman, Eric G. Aguero, Carolyn E. Reed, Anand K. Sharma> ;Japanese Journal of Clinical Oncology. 2011 Mar 1
12 citations
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
John M. Watkins, Amy E. Wahlquist, A. Jason Zauls, Keisuke Shirai, Elizabeth Garrett-Mayer, Eric G. Aguero, Gerard A. Silvestri, Carol A. Sherman, Anand K. Sharma> ;Journal of Medical Imaging and Radiation Oncology. 2010 Oct 1
33 citations
Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer
Bree N. Ruppert, John M. Watkins, Keisuke Shirai, Amy E. Wahlquist, Elizabeth Garrett-Mayer, Eric G. Aguero, Carol A. Sherman, Carolyn E. Reed, Anand K. Sharma> ;American Journal of Clinical Oncology. 2010 Aug 1
17 citations
Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative an...
John M. Watkins, John A. Fortney, Amy E. Wahlquist, Keisuke Shirai, Elizabeth Garrett-Mayer, Eric G. Aguero, Carol A. Sherman, Andrew T. Turrisi, Anand K. Sharma> ;Japanese Journal of Radiology. 2010 Jun 30
14 citations
Factors Associated With Severe Acute Esophagitis From Hyperfractionated Radiotherapy With Concurrent Chemotherapy for Limited-Stage Small-Cell Lung Cancer
John M. Watkins, Amy E. Wahlquist, Keisuke Shirai, Elizabeth Garrett-Mayer, Eric G. Aguero, John A. Fortney, Carol A. Sherman, Anand K. Sharma> ;International Journal of Radiation Oncology, Biology, Physics. 2009 Jul 15
3 citations
Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
Matthew Beldner, Carol A. Sherman, Mark R. Green, Elizabeth Garrett-Mayer, Uzair B. Chaudhary, Mario L. Meyer, Andrew S. Kraft, Alberto J. Montero> ;BMC Cancer. 2007 Dec 20
7 citations
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
John Hayslip, Uzair B. Chaudhary, Mark R. Green, Mario L. Meyer, Steven Dunder, Carol A. Sherman, Shanta Salzer, Andrew S. Kraft, Alberto J. Montero> ;BMC Cancer. 2007 Dec 3
5 citations
Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
James J. Urbanic, Andrew T. Turrisi, Anand K. Sharma, Gerard A. Silvestri, Todd E. Williams, Kenneth N. Vanek, Carol A. Sherman> ;Journal of Thoracic Oncology. 2006 Feb 1
9 citations
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer.
Carol A. Sherman, James E. Herndon, Dorothy Watson, Mark R. Green> ;Lung Cancer. 2004 Sep 1
Conformal high-dose external radiation therapy (CHERT) alone for medically inoperable non-small cell lung cancer (MILC).
Urbanic JJ, Turrisi A, Sharma A, Silvestri G, Nietert P, Williams T, Vanek K, Sherman C, Harley R> ;J. Clin. Oncol.. 2004-07-15
4 citations
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors
Caio M. S. Rocha Lima, Carlo V. Catapano M.D., Daniel Pacheco, Carol A. Sherman, Greg Oakhill, Chaudhry Mushtaq, Kimberly D. Freeman, Mark R. Green> ;Cancer. 2004 Jun 15
52 citations
Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood
Michael Mitas, Loretta Hoover, Gerard A. Silvestri, Carolyn E. Reed, Mark R. Green, Andrew T. Turrisi, Carol A. Sherman, Kaidi Mikhitarian, David J. Cole, Mark I. Bloc...> ;The Journal of Molecular Diagnostics. 2003 Nov 1
2 citations
The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of s...
A Turrisiiii, J Bogart, Carol A. Sherman, Gerard A. Silvestri> ;Respiratory Care Clinics of North America. 2003 Jun 1
10 citations
Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer.
Bart Frizzell, Debajyoti Sinha, Todd E. Williams, Carolyn E. Reed, Carol A. Sherman, Andrew T. Turrisi> ;American Journal of Clinical Oncology. 2003 Jun 1
53 citations
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
Wallace Akerley, James E. Herndon, Merrill J. Egorin, Alan P. Lyss, Hedy L. Kindler, Dianne M. Savarese, Carol A. Sherman, D. Marc Rosen, Donna Hollis, Mark J. Ratain,...> ;Cancer. 2003 May 15
28 citations
Locally advanced esophageal cancer.
Carol A. Sherman, Andrew T. Turrisi, Michael B. Wallace, Carolyn E. Reed> ;Current Treatment Options in Oncology. 2002 Dec 1
14 citations
Caring for the Dying Patient With Lung Cancer
Gerard A. Silvestri, Carol A. Sherman, Todd E. Williams, Swan-Swan Leong, Patrick A. Flume, Andrew T. Turrisi> ;Chest. 2002 Sep 1
6 citations
Irinotecan and gemcitabine in patients with solid tumors: phase I trial.
Caio Max S. Rocha Lima, Swan-Swan Leong, Carol A. Sherman, Joshua A. Perkel, Terri Putman, Ahmad R. Safa, M. R. Green> ;Oncology. 2002 May 2
15 citations
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer.
Rocha Lima Cm, Carol A. Sherman, Brescia Fj, Brunson Cy, Mark R. Green> ;Oncology. 2001 Mar 2
1 citations
Docetaxel followed by gemcitabine and irinotecan in solid tumors.
Rocha Lima Cm, James J. Urbanic, Carol A. Sherman, Brescia Fj, Mark R. Green> ;Oncology. 2001 Jan 1
Join now to see all

Hospital Affiliations

MUSC Health University Medical CenterCharleston, South Carolina
Ralph H. Johnson Veterans Affairs Medical CenterCharleston, South Carolina

CarolAShermanMD

Dr. Sherman is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.